Your search for comorbidities returned 243 results

Latest findings are from a post hoc meta-analysis of pooled data from the DAPA-HF and DELIVER trials.

Patients with heart failure with reduced ejection fraction who received any guideline-directed medical therapy were less likely to die within 1 year of implantable cardioverter-defibrillator placement.

Researchers assessed the relationship between depression and incidence of stroke in patients with a history of myocardial infarction.

Management of patients with a recently implanted left ventricular assist device necessitates a thorough understanding of the postimplant period and of common critical care issues that may arise from the operating room to critical care discharge.

Researchers sought to determine if catheter ablation better improves clinical outcomes compared with pharmacological therapy in patients with HF and AF.

Approximately one-third of young patients were found to have left ventricular systolic dysfunction after acute myocardial infarction.

Patients with heart failure, severe pulmonary hypertension, and a preserved ejection fraction of ≥50% had a worse prognosis when compared with other patients with heart failure and severe pulmonary hypertension.

Investigators assessed outcomes following discontinuation of statins while maintaining the use of other drugs in older patients receiving polypharmacy.

Researchers compared heart transplant candidates and patients considering mechanical circulatory support to determine differences in health-related quality of life.

A study was conducted to assess the effect of sarcopenia and cachexia on clinical outcomes in older patients with heart failure.